0 Items
Select Page

Coronavirus Receptors

The Native Antigen Company manufacturers highly purified virus-host cell receptors using state-of-the-art expression and purification techniques. On request we can also undertake custom preparation of recombinant and native proteins for a broad range of disease states.

Coronavirus Receptors Background

Coronaviruses primarily infect the upper respiratory and gastrointestinal tract of mammals and birds. Six different currently known strains of coronaviruses infect humans and they are believed to cause a significant percentage of all common colds in human adults and children. Coronaviruses can also cause more serious diseases including severe acute respiratory syndrome (SARS), a viral respiratory disease of zoonotic origin caused by the SARS coronavirus (SARS-CoV). Between November 2002 and July 2003, an outbreak of SARS in southern China resulted in an eventual 8,098 cases, resulting in 774 deaths across 37 countries.

Coronaviruses are enveloped viruses with a positive-sense single-stranded RNA genome and with a nucleocapsid of helical symmetry. The genomic size of coronaviruses ranges from approximately 26 to 32 kilobases, the largest for an RNA virus. They can be classified into at least three major genera, α, β, and γ (formerly group 1, 2, and 3, respectively). Prototypic β-genus coronaviruses include severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV).

The virus obtained its name from the characteristic halo appearance of virions under electron microscopy with a fringe of large, bulbous surface projections comprising the viral spike (S) peplomers, which are proteins that populate the surface of the virus and determine host tropism. Other structural proteins of coronaviruses are the envelope (E), membrane (M) and nucleocapsid (N).

The envelope-anchored spike protein mediates coronavirus entry into host cells by first binding to a receptor on the host cell surface and then fusing viral and host membranes. In the specific case of the SARS coronavirus, a defined receptor-binding domain on S mediates the attachment of the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). Some coronaviruses (specifically the members of Betacoronavirus subgroup A) also have a shorter spike-like protein called hemagglutinin esterase (HE).

Coronaviruses recognize a variety of host receptors, for example, although HCoV-NL63 and SARS-CoV belong to the α-genus and β-genus, respectively, their S1-CTDs recognize the same receptor, angiotensin-converting enzyme 2 (ACE2). Therefore, Coronaviruses have evolved a complex receptor recognition pattern: (i) coronaviruses use one or both S1 domains as RBDs; (ii) highly similar coronavirus S1-CTDs within the same genus can recognize different protein receptors, whereas very different coronavirus S1-CTDs from different genera can recognize the same protein receptor; and (iii) coronavirus S1-NTDs can recognize either protein or sugar receptors.

 

References

  • Bosch et al. (2003). The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex. J Virol 77:8801–8811.
  • de Groot et al. (2011). Family Coronaviridae. In AMQ King, E Lefkowitz, MJ Adams, EB Carstens (eds.). Ninth Report of the International Committee on Taxonomy of Viruses. Elsevier, Oxford. pp. 806–828.
  • González et al. (2003). A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae. Arch Virol 148:2207–2235.
  • Li et al. (2005). Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 309 (5742): 1864–8.
  • Li et al. (2015). Receptor Recognition Mechanisms of Coronaviruses: a Decade of Structural Studies. J. Virol. 89:4
  • Spaan et al. (1988). Coronaviruses: structure and genome expression. J Gen Virol 69(Pt 12):2939–2952
  • Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. World Health Organization (WHO). 31 October 2008.

Coronavirus Receptors

We have manufactured different virus receptor proteins, including the coronavirus receptor offered here. Our recombinant proteins are produced to the highest quality, using in-house bespoke expression and purification methods.

 

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

A Q&A with David Flavell of Leukaemia Busters

In this blog, we speak with Dr. David Flavell about his scientific career, the legacy of Leukaemia Busters, and the recent impact that COVID-19 has had on his research.Tell me about your scientific background David. I was born in a seaside town called Southport in...

Avoiding the Immunopathology Pitfalls of a COVID-19 Vaccine

In the second of a three-part series on COVID-19 vaccines, we explore the potential challenges in stimulating safe vaccine responses and outline the role that diagnostics will play in guiding their development.Rogue Responses Antibodies play a crucial role in...

The Bumpy Road to a Cytomegalovirus Vaccine

The development of a cytomegalovirus vaccine has been 50 years in the making. Are there any technologies in the pipeline that could prompt a breakthrough? This article was originally posted online at The Medicine Maker, a Texere publication.To say that...

Why We Need Antigen and Antibody Tests for COVID-19

RT-PCR is the workhorse of viral diagnosis and has been invaluable in COVID-19 case confirmation and isolation guidance. However, while fast and sensitive, PCR suffers from some inherent drawbacks that limit it to diagnosis during the acute phase of infection. To...

Gonorrhea: What’s Currently in the Clinical Pipeline?

This article was written by our friends at Infectious Diseases Hub, a free-to-access website that aims to deliver up-to-date, essential research and information on all aspects of microbiology, virology, mycology and parasitology – from bench to bedside....

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

7 + 12 =

Live Customer Feedback

Join our mailing list

* indicates required